In 2023, software and tech hosting/cloud services/MSP companies had a much higher spending share on IT than other industries, amounting to 19 percent and 16 percent of their revenues, respectively. By contrast, the consumer products and services industry invested only around five percent of their revenue in IT. Overall, all industries increased their IT spending per revenue share in 2023 compared to the previous year.

Cloud computing

Cloud computing is an essential IT service that utilizes a network of distant servers hosted over the Internet to store, handle, and process data. This segment of IT services was projected to generate revenues exceeding 670 billion U.S. dollars in 2024 and is expected to continue its rapid growth trajectory. Managed Services Providers (MSPs) provide companies with the expertise and technical support to manage their cloud infrastructure and products without the need for in-house specialists. Cloud computing is segmented into three main categories.

Software as a Service (SaaS) delivers software applications over the Internet, on a subscription basis, freeing companies from software and hardware management. Infrastructure as a Service (IaaS) offers a virtualized computing infrastructure managed over the Internet, allowing businesses to avoid the costs and complexities of purchasing and managing physical servers and data center infrastructure. Platform as a Service (PaaS) provides a platform allowing customers to develop, run, and manage applications without the complexity of building and maintaining the infrastructure.

North American companies are investing in technology initiatives at a higher level than European organizations, with IT spending accounting for 13 percent of company revenue. European companies' IT expenditure lags behind the global average, which stood at 10 percent of company revenue at the time of the survey.

The statistic presents IT spending as a percentage of company revenue worldwide as of 2019, by industry sector. In the financial services industry, IT spending ranged between 4.4 at the 25th percentile to 11.4 percent at the 75 percentile as of 2019.

The statistic presents the average IT budget as percentage of corporate revenue in Japan in fiscal year 2016, broken down by industry. In the measured period, the financial services industry had the highest IT budget against corporate revenue at around 6.1 percent.

This statistic presents the bank spending on information technology as share of bank revenues in the United States as of December 2017, by bank size. According to the source, U.S. banks with assets worth more than ten billion U.S. dollars, spent 5.3 percent of their revenues on development of information technology.

The statistic shows internal research and development (R&D) expenditure of industrial enterprises in China between 2013 and 2023, as a percentage of revenue. In 2023, internal R&D expenditure of industrial companies in China amounted to 1.55 percent of revenue.

This statistic depicts the spending on research and development by Eli Lilly and Company, shown as a share of revenue from 2010 to 2024. In 2024, the company spent some 24 percent of its revenues on R&D purposes. Eli Lilly and Company is an international pharmaceutical company, headquartered in Indianapolis, Indiana.

According to an annual survey among chief marketing officers (CMOs) in North America and Northern and Western Europe, 7.7 percent of their employers' revenues were allocated to marketing in 2024, down from 9.1 percent a year earlier. In 2016, that share peaked at over 12 percent.

Diversity among CMOs in the United States… A study fielded in the U.S. revealed that women accounted for half of Fortune 500 companies' CMOs in 2023. Two years before, the share stood at 44 percent. Meanwhile, the percentage of people belonging to historically underrepresented racial or ethnic groups working as CMOs at the same group of organizations reached 12 percent in 2023, down from 14 percent a year earlier.

… and in the United Kingdom A 2024 survey showed that, on average, the share of women among marketing directors or CMOs in the UK surpassed 53 percent. Despite that female majority, several British companies did not offer a marketing leadership position to begin with. According to the same study, less than two-thirds of UK companies had a CMO or marketing director.

This statistic shows the total direct learning expenditure of organizations worldwide expressed as a percentage of revenue from 2010 to 2017. During the survey, the consolidated expenditure on direct learning reported by respondents for 2017 amounted to 1.16 percent of their consolidated revenue.

This statistic displays the amount spent worldwide on research and development in medtech between 2011 and 2024, as a percentage of medtech revenue. In 2017, 7.1 percent of total global medical technology revenue were spent on R&D in medtech. Medical technology is used for diagnosis, monitoring, or treatment of diseases or medical conditions.

During a September 2024 survey among chief marketing officers (CMOs) from for-profit companies in the United States, respondents reported that, on average, 7.7 percent of their employers' revenues were allocated to marketing activities. That was the lowest average share for an autumn edition of the survey since August 2018.

This statistic shows Johnson & Johnson's research and development expenditure as a percent of sales from 2005 to 2024. Johnson & Johnson is a company specialized in pharmaceuticals, medical devices and diagnostics. The company is headquartered in New Brunswick, New Jersey. In 2024, the company's R&D expenditure represented some 19.4 percent of its total sales.

In relation to total revenue, the pharmaceutical industry is among the biggest investors in research and development (R&D). Based on data from the Pharmaceutical Research and Manufacturers of America (PhRMA), the industry in the United States spent around 21 percent of global revenues on R&D in 2023. Analyzing the revenues and R&D expenditure Members of the PhRMA trade group generated global revenues of approximately 448 billion U.S. dollars in 2023, with domestic revenues accounting for over 70 percent of that figure. With regard to R&D expenditure, PhRMA members spent some 96 billion U.S. dollars worldwide in 2023, with spending in their domestic market accounting for around 74 percent of the global figure. Product lifecycles in the pharmaceutical industry Pharmaceutical manufacturers require time and money if they are to develop new innovative medicines: it can take 10 to 15 years to develop a new medicine, at an average cost of approximately 2.6 billion U.S. dollars. Due to patents and exclusivity, brand name drugs can expect to be on the market for an average of twelve years before a generic version enters. Generics contain the same active ingredients as branded drugs but can be considerably cheaper. The healthcare system in the United States generated around 408 billion U.S. dollars in savings through generic medicines in 2022.

This statistic displays the share of the construction sector respondents' annual sales volume spent on their company's information technology (IT) in the United States as of 2018. As of that year, 46 percent of the surveyed respondents from the U.S. construction sector stated that their companies spent less than one percent of their annual sales volume on IT.

During a September 2024survey among chief marketing officers (CMOs) from for-profit companies in the United States, respondents reported that, on average, corporations selling consumer packaged goods (CPG) allocated approximately 18.09 percent of their total budgets to marketing expenses. The education and the communications and media segments followed, with shares of about 14.6 and 13.8 percent, respectively. The CPG market on the spotlight CPG marketing promotes perishable consumer goods such as food, beverages, or household products. As these items are used and replenished regularly, the CPG industry is known as a highly competitive playing field, and brands rely on effective marketing campaigns to stand out among the crowd. Top advertising spenders Amazon was the top advertiser in the U.S. in 2022, with over 13 billion U.S. dollars in spending. Procter & Gamble was the leading advertiser from the CPG industry that year, which comes as no surprise considering the conglomerate's size and extensive brand portfolio. Many of the world’s most popular cleaning and personal care brands, such as Pampers, Braun, Gillette, and Pantene, fall under the P&G umbrella, making the company a multinational CPG giant.

In 2022, the highest share of research and development spending (R&D) was made within the hardware technology producing industry, accounting for a total of nearly 23 percent of the global R&D spending. The health sector and software producers followed in second at nearly 21 percent each. In total, global R&D spending reached 2.5 trillion U.S. dollars in 2022.

Health industry and COVID-19

The high share spent by the health industry must be seen in relation with the COVID-19 pandemic that started spreading in late 2019 and caused deaths, lockdowns, and restrictions throughout 2020 and onwards. As governments and pharmaceutical companies sought to find an efficient vaccine against the virus, investment in research continued to increase. However, regardless of the pandemic, R&D spending within health care is essential in order to combat a variety of diseases, from small pox via malaria to cancer.

Information and communication technology

As people around the the world become more and more dependent on information and communication technology, research spending by companies producing hardware and software continues to increase as these seek to further develop. For instance, all the seven companies with the highest R&D spending in 2022 were either software or hardware producing companies. The largest single investor was the software giant Amazon.

This statistic represents Swiss-based pharmaceutical company Novartis' expenditure on research and development, from 2004 to 2024, as a percentage of revenue. In 2024, research and development expenditure accounted for about one fifth of Novartis' total revenue. The high percentage in 2023 was driven by the spin-off of Novartis' generics division Sandoz during that year.

In 2024, spending on devices amounted to around734 billion U.S. dollars globally, an increase of around 5.1 percent from the previous year. Global IT spending is expected to reach approximately 5.6 trillion U.S. dollars in 2025, increasing by about four percent compared to 2024. Around 810 billion U.S. dollars are forecast to be spent on devices.

In 2021, the agrochemical and fertilizer sector stood out in the chemical industry by having the highest research and development (R&D) spending relative to its revenue, with investments accounting for 5.9 percent of the sector’s total revenue. This equates to an R&D investment of 5.7 billion U.S. dollars for that year.

This statistic represents the percentage of expenditure on research and development of total revenue in 2022, by industrial sector. The data was generated from the numbers of the 2,500 top companies worldwide. In 2022, spending on research and development accounted for around 13 percent of the total revenue in the health industries.